Results 221 to 230 of about 1,172,272 (355)

PROSTATE CANCER MANAGEMENT IN MOEWARDI HOSPITAL SURAKARTA FROM JANUARY 2000 – DECEMBER 2006

, 1970
Endi Prilansa Mahadi, Suharto Widjanarko
openalex   +1 more source

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. [PDF]

, 1984
S R Ahmed, Stephen M. Shalet, J. Grant, Anthony Howell, N. J. Blacklock   +4 more
openalex   +1 more source

Advancing Clinical Medicine with Raman Spectroscopy: Current Trends and Future Perspectives

Advanced Photonics Research, EarlyView.
Raman spectroscopy and microscopy may become excellent tools in clinical medicine, including hematology, oncology, infectious diseases, neurology, gastroenterology, reproductive medicine, rheumatology, and cardiovascular research. However, many challenges such as signal interference, standardization issues, and limited clinical application need to be ...
Jiří Bufka, Lenka Vaňková, Josef Sýkora, Věra Křížková, Jan Schwarz, Petr Bouř   +5 more
wiley   +1 more source

Rectal examination for early detection of prostatic cancer.

, 1983
Y. Katsuoka
openalex   +2 more sources

Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility

Advanced Therapeutics, EarlyView.
This study reports the heterogeneity spectrum of circulating tumor cells. The factors involved in the spectrum promote CTCs to overcome barriers in the metastatic cascade but impact the clinical outcome of cancer patients. In summary, the heterogeneities in association with CTCs ultimately reduce patient survival and facilitate increasing mortality of ...
Md Kowsar Alam, Lu Yanjun, Bee Luan Khoo, Tongxu Si, Heng Zou, Mengsu Yang   +5 more
wiley   +1 more source

The immune landscape of systemic inflammation in prostate cancer. [PDF]

Cancer Biol Med
Zhang L, Fu J, Liu X, Feng S, Leng Y.
europepmc   +1 more source

FAST NEUTRON THERAPY FOR PROSTATIC CANCER

, 1983
Masayuki Maruoka, Ken Ando, Kuniyoshi Nozumi, Haruo Itô, Jun Shimazaki, Osamu Matsuzaki, Shinroku Morita, Hiroshi Tsumemoto   +7 more
openalex   +2 more sources

Enhanced Doxorubicin Cytotoxicity on Breast Cancer Spheroids by Aptamer Targeted Co‐Delivery with Hyaluronidase

Advanced Therapeutics, EarlyView.
Breast cancer is one of the most prevalent solid tumors in women. Doxorubicin is loaded mesoporous silica nanoparticles, capped with HER2‐specific aptamers, and the particle surface is functionalized with hyaluronidase. This dual‐functionalized nanocarrier system offers a promising solution for the drug resistance by solid tumors.
Murat Kavruk, Dide Su Demirel, Farzaneh Bonyadi, Buket Çakmak Güner, Ali Doğan Dursun, Cekdar Vakifahmetoglu, Bilge Güvenç Tuna, Uğur Şahin, Veli Cengiz Ozalp   +8 more
wiley   +1 more source

Competition for nutrients or cell intrinsic programming? – Metabolic mechanisms behind the tumor promoting immune microenvironment in cancer

Signal Transduction and Targeted Therapy, 2021
Yuequn Niu, Thomas Mayr, Michael H. Muders   +2 more
doaj   +1 more source

SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients. [PDF]

PLoS One
Murtola TJ, Skantsi KM, Siltari A, Talala K, Taari K, Tammela TLJ, Schleutker J, Auvinen A, Sipeky C.   +8 more
europepmc   +1 more source